Topic Podcasts - PsA Part2 Save
ACR 2022 Appraisal, Praise & Critique (11.18.2022)
Best of ACR Day Two in PSA
Efficacy and Safety Results from BE OPTIMAL in PsA
JAK inhibitors in rheumatic diseases
Oligoarticular PsA: FOREMOST Study
Opioid use in PsA and SpA
PET CT Imaging to Define Risk of Progression from PSO to PsA
PsA and SPA: Cyclers, Switchers, Who is the Winner?
Switch vs Cycle in PsA
Women vs. Men: Response to Treatment in Seronegative Arthritis
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.